ruthenium has been researched along with Hypoxia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, PC; Cameron, CG; Cole, HD; Hodges, RO; Lifshits, LM; McFarland, SA; Ramasamy, E; Roque, JA; Shi, G | 1 |
| Cheng, B; Hong, XJ; Li, WG; Ling, YY; Mao, ZW; Su, Q; Tan, CP; Wang, WJ; Wu, T; Zhang, CY; Zhou, JY | 1 |
| Dao, A; Huang, H; Wei, S; Wu, H | 1 |
| Wilson, JJ; Woods, JJ | 1 |
| Chao, H; Ji, L; Kuang, S; Liao, X; Liu, J; Luo, D; Rees, TW; Wang, J; Wei, F; Zhang, X | 1 |
| Askes, SHC; Bonnet, S; Ernst, D; Hopkins, SL; Lameijer, LN; Le Dévédec, SE; Meijer, MS | 1 |
| Achilefu, S; Black, KCL; Gilson, RC; Lane, DD | 1 |
| Bu, J; Bu, W; Du, J; Liu, J; Liu, Y; Shi, J; Sun, Y | 1 |
| Allison, SJ; Hebden, AJ; Henderson, IR; Lord, RM; McGowan, PC; Pask, CM; Phillips, RM; Shepherd, SL | 1 |
| Chao, H; Chen, Y; Huang, H; Ji, L; Wang, J; Zeng, L; Zhao, D | 1 |
| Glover, CJ; Gransbury, GK; Harris, HH; Hughes, JN; Kappen, P; Lay, PA; Levina, A; Musgrave, IF | 1 |
| Kimura, Y; Komatsu, H; Nishimoto, S; Son, A; Tanabe, K; Yamada, H; Yoshihara, K | 1 |
| Aldinucci, C; Benocci, A; Frosini, M; Garcia, JB; Meini, A; Palmi, M; Pessina, GP; Sgaragli, GP | 1 |
| Chaplin, DJ; Collingridge, DR; Hill, SA; Lynch, EM; Vojnovic, B; Wardman, P; Young, WK | 1 |
| Blower, PJ; Dilworth, JR; Maurer, RI; Mullen, GD; Reynolds, CA; Zheng, Y | 1 |
1 review(s) available for ruthenium and Hypoxia
| Article | Year |
|---|---|
Towards new transition metal-based hypoxic selective agents for therapy and imaging.
Topics: Antineoplastic Agents, Alkylating; Copper; Drug Carriers; Humans; Hypoxia; Metals; Nitrogen Mustard Compounds; Radioisotopes; Radionuclide Imaging; Rhenium; Ruthenium | 2001 |
14 other study(ies) available for ruthenium and Hypoxia
| Article | Year |
|---|---|
Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Hypoxia; Photochemotherapy; Photosensitizing Agents; Reproducibility of Results; Ruthenium | 2022 |
Ru(II)-modified TiO
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytokines; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunotherapy; Metal Nanoparticles; Mouth Neoplasms; Nanoparticles; Photosensitizing Agents; Rats; RNA, Small Interfering; Ruthenium; Squamous Cell Carcinoma of Head and Neck; Titanium; Tumor Microenvironment | 2022 |
Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Humans; Hypoxia; Ligands; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium | 2023 |
A Dinuclear Persulfide-Bridged Ruthenium Compound is a Hypoxia-Selective Hydrogen Sulfide (H
Topics: Animals; Coordination Complexes; Hydrogen Sulfide; Hypoxia; Oxidation-Reduction; Rats; Ruthenium; Sulfides | 2021 |
Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia.
Topics: Graphite; Humans; Hydrogen Peroxide; Hypoxia; Nitrogen Compounds; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium | 2021 |
A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells.
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hypoxia; Light; Nicotinamide Phosphoribosyltransferase; Organometallic Compounds; Photochemical Processes; Photochemotherapy; Ruthenium; Structure-Activity Relationship | 2017 |
Hybrid TiO
Topics: Hypoxia; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium; Titanium | 2017 |
Ultrasensitive nanosensors based on upconversion nanoparticles for selective hypoxia imaging in vivo upon near-infrared excitation.
Topics: Adsorption; Animals; Cell Line, Tumor; Humans; Hypoxia; Microscopy, Confocal; Molecular Structure; Nanoparticles; Nanotechnology; Organometallic Compounds; Oxygen; Particle Size; Ruthenium; Surface Properties; Zebrafish | 2014 |
Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; DNA Breaks, Single-Stranded; Humans; Hypoxia; Iridium; Models, Molecular; Neoplasms; Ruthenium | 2015 |
Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Hep G2 Cells; Humans; Hypoxia; Ligands; Lung Neoplasms; Ruthenium | 2015 |
Comparison of KP1019 and NAMI-A in tumour-mimetic environments.
Topics: Antineoplastic Agents; Dimethyl Sulfoxide; Humans; Hypoxia; Indazoles; Neuroblastoma; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment; X-Ray Absorption Spectroscopy | 2016 |
Ruthenium complexes with hydrophobic ligands that are key factors for the optical imaging of physiological hypoxia.
Topics: Animals; Coordination Complexes; Hydrophobic and Hydrophilic Interactions; Hypoxia; Ligands; Luminescent Measurements; Mice; Molecular Structure; Optical Imaging; Phenanthrolines; Photochemistry; Pyrenes; Pyridines; Ruthenium | 2013 |
Potentiation of intracellular Ca2+ mobilization by hypoxia-induced NO generation in rat brain striatal slices and human astrocytoma U-373 MG cells and its involvement in tissue damage.
Topics: Animals; Anticoagulants; Astrocytoma; Calcium; Cell Line, Tumor; Corpus Striatum; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Free Radical Scavengers; Fura-2; Heparin; Humans; Hydro-Lyases; Hypoxia; Imidazoles; In Vitro Techniques; Intracellular Space; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Perfusion; Rats; Rats, Sprague-Dawley; Ruthenium; Ryanodine | 2003 |
Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor.
Topics: Animals; Female; Fluorescent Dyes; Hypoxia; Luminescent Measurements; Mice; Mice, Inbred CBA; Organometallic Compounds; Oxygen; Phenanthrolines; Polarography; Ruthenium; Sarcoma, Experimental | 1997 |